Renaissance Technologies - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 35 filers reported holding SINOVAC BIOTECH LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 2.9%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$1,5370.0%2,375,8410.0%0.00%
+50.0%
Q2 2023$1,537
-99.9%
2,375,8410.0%0.00%0.0%
Q3 2022$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q2 2022$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q4 2021$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q3 2021$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q2 2021$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q1 2021$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q4 2020$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q3 2020$1,537,0000.0%2,375,8410.0%0.00%
+100.0%
Q2 2020$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q1 2020$1,537,0000.0%2,375,8410.0%0.00%0.0%
Q4 2019$1,537,000
-90.0%
2,375,8410.0%0.00%
-92.3%
Q3 2019$15,372,0000.0%2,375,8410.0%0.01%
-7.1%
Q2 2019$15,372,0000.0%2,375,8410.0%0.01%0.0%
Q1 2019$15,372,000
-7.3%
2,375,841
-0.5%
0.01%
-22.2%
Q4 2018$16,577,000
-11.1%
2,388,573
-2.4%
0.02%
-5.3%
Q3 2018$18,656,000
-55.2%
2,448,276
-52.7%
0.02%
-17.4%
Q2 2018$41,625,000
+83.2%
5,172,930
+96.0%
0.02%
-8.0%
Q1 2018$22,726,000
+7.3%
2,639,500
-1.8%
0.02%
+8.7%
Q4 2017$21,177,000
+38.4%
2,687,400
+23.8%
0.02%
+27.8%
Q3 2017$15,300,000
+24.9%
2,170,200
+19.6%
0.02%
+12.5%
Q2 2017$12,247,000
+27.3%
1,814,300
+8.0%
0.02%
+23.1%
Q1 2017$9,623,000
+7.0%
1,679,490
+10.1%
0.01%
-7.1%
Q4 2016$8,996,000
+3.4%
1,524,800
+3.4%
0.01%
-6.7%
Q3 2016$8,703,000
+5.1%
1,475,000
+5.7%
0.02%
-6.2%
Q2 2016$8,279,000
-2.9%
1,396,100
+4.6%
0.02%0.0%
Q1 2016$8,528,000
+10.1%
1,334,600
-1.4%
0.02%
-5.9%
Q4 2015$7,745,000
+17.9%
1,354,100
+4.7%
0.02%
+6.2%
Q3 2015$6,567,000
-1.0%
1,292,779
+2.3%
0.02%
+6.7%
Q2 2015$6,632,000
+12.7%
1,263,200
+6.5%
0.02%
+15.4%
Q1 2015$5,884,000
-4.4%
1,186,200
+0.8%
0.01%
-13.3%
Q4 2014$6,152,000
+1.0%
1,176,362
-7.1%
0.02%
-11.8%
Q3 2014$6,089,000
-8.1%
1,266,000
+7.7%
0.02%
+13.3%
Q2 2014$6,627,000
-10.8%
1,175,000
+13.9%
0.02%
-16.7%
Q1 2014$7,428,000
+15.0%
1,031,711
-2.2%
0.02%
+20.0%
Q4 2013$6,457,000
+20.4%
1,054,996
+17.7%
0.02%
+15.4%
Q3 2013$5,362,000
+246.6%
896,600
+127.8%
0.01%
+225.0%
Q2 2013$1,547,000393,6000.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q3 2017
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,000,0007.22%
Vivo Capital, LLC 5,900,000$38,173,0004.18%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.82%
Financial Gravity Asset Management, Inc. 988$3,197,6860.04%
Yorktown Management & Research Co Inc 149,786$4,4940.01%
Renaissance Technologies 2,375,841$1,5370.00%
WELLS FARGO & COMPANY/MN 1,661$10,7470.00%
NORTHERN TRUST CORP 13,787$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$2,6660.00%
View complete list of SINOVAC BIOTECH LTD shareholders